Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria.

Afficher d'autres versions (1)

PURPOSE: Dihydroartemisinin-piperaquine (DP) is a fixed-dose artemisinin-based combination treatment. Field pharmacokinetic studies would be simplified and facilitated by being able to use small volume capillary assays rather than venous blood. The aim of this study was to describe the relationship...

Description complète

Détails bibliographiques
Auteurs principaux:	Ashley, E, Stepniewska, K, Lindegardh, N, Annerberg, A, Tarning, J, Mcgready, R, Phaiphun, L, Singhasivanon, P, White, N, Nosten, F
Format:	Journal article
Langue:	English
Publié:	2010

Documents similaires

Comparison of plasma, venous and capillary blood levels of piperaquine in patients with uncomplicated falciparum malaria
par: Ashley, E, et autres
Publié: (2010)

Population pharmacokinetics of piperaquine after two different treatment regimens of dihydroartemisinin piperaquine in patients with acute uncomplicated falciparum malaria in Thailand
par: Tarning, J, et autres
Publié: (2007)

Pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated falciparum malaria.
par: Rijken, M, et autres
Publié: (2011)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria.
par: Adam, I, et autres
Publié: (2012)

Population pharmacokinetics of piperaquine after two different treatment regimens with dihydroartemisinin-piperaquine in patients with Plasmodium falciparum malaria in Thailand.
par: Tarning, J, et autres
Publié: (2008)

Pharmacokinetics of piperaquine in pregnant women in Sudan with uncomplicated Plasmodium falciparum malaria
par: Adam, I, et autres
Publié: (2012)

Comparison of lumefantrine, mefloquine, and piperaquine concentrations between capillary plasma and venous plasma samples in pregnant women with uncomplicated falciparum and vivax malaria
par: Saito, M, et autres
Publié: (2024)

Population pharmacokinetic assessment of the effect of food on piperaquine bioavailability in patients with uncomplicated malaria.
par: Tarning, J, et autres
Publié: (2014)

Population pharmacokinetics of lumefantrine in pregnant women treated with artemether-lumefantrine for uncomplicated Plasmodium falciparum malaria.
par: Tarning, J, et autres
Publié: (2009)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria.
par: Tarning, J, et autres
Publié: (2012)

Population pharmacokinetics and pharmacodynamics of piperaquine in children with uncomplicated falciparum malaria
par: Tarning, J, et autres
Publié: (2012)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
par: Mcgready, R, et autres
Publié: (2006)

The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria.
par: McGready, R, et autres
Publié: (2009)

Electrocardiographic safety evaluation of dihydroartemisinin piperaquine in the treatment of uncomplicated falciparum malaria.
par: Mytton, O, et autres
Publié: (2007)

Population pharmacokinetics of dihydroartemisinin and piperaquine in pregnant and nonpregnant women with uncomplicated malaria.
par: Tarning, J, et autres
Publié: (2012)

Population Pharmacokinetics of Dihydroartemisinin and Piperaquine in Pregnant and Nonpregnant Women with Uncomplicated Malaria
par: Tarning, J, et autres
Publié: (2012)

Randomized, controlled dose-optimization studies of dihydroartemisinin-piperaquine for the treatment of uncomplicated multidrug-resistant falciparum malaria in Thailand.
par: Ashley, E, et autres
Publié: (2004)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine
par: Zongo, I, et autres
Publié: (2014)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
par: Annerberg, A, et autres
Publié: (2011)

A small amount of fat does not affect piperaquine exposure in patients with malaria.
par: Annerberg, A, et autres
Publié: (2011)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated Plasmodium falciparum malaria in Sudan.
par: Hoglund, R, et autres
Publié: (2012)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria.
par: Ashley, E, et autres
Publié: (2007)

Pharmacokinetic study of artemether-lumefantrine given once daily for the treatment of uncomplicated multidrug-resistant falciparum malaria
par: Ashley, E, et autres
Publié: (2007)

A randomized, controlled study of a simple, once-daily regimen of dihydroartemisinin-piperaquine for the treatment of uncomplicated, multidrug-resistant falciparum malaria.
par: Ashley, E, et autres
Publié: (2005)

Population pharmacokinetic assessment of a new regimen of mefloquine used in combination treatment of uncomplicated falciparum malaria.
par: Ashley, E, et autres
Publié: (2006)

Efficacy and day 7 plasma piperaquine concentrations in African children treated for uncomplicated malaria with dihydroartemisinin-piperaquine.
par: Issaka Zongo, et autres
Publié: (2014-01-01)

A population pharmacokinetic model of piperaquine in pregnant and non-pregnant women with uncomplicated <it>Plasmodium falciparum</it> malaria in Sudan
par: Hoglund Richard M, et autres
Publié: (2012-11-01)

Erratum:The pharmacokinetics of artemether and lumefantrine in pregnant women with uncomplicated falciparum malaria(European Journal of Clinical Pharmacology (2006) 62 (1021-1031) DOI: 10.1007/s00228-006-0199-7)
par: Mcgready, R, et autres
Publié: (2009)

Quantification of the antimalarial piperaquine in plasma.
par: Tarning, J, et autres
Publié: (2008)

Pitfalls in estimating piperaquine elimination.
par: Tarning, J, et autres
Publié: (2005)

Dihydroartemisinin - piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report
par: Rijken, M, et autres
Publié: (2007)

A randomised controlled trial of artemether-lumefantrine versus artesunate for uncomplicated plasmodium falciparum treatment in pregnancy.
par: Mcgready, R, et autres
Publié: (2008)

Pharmacokinetics of dihydroartemisinin following oral artesunate treatment of pregnant women with acute uncomplicated falciparum malaria.
par: Mcgready, R, et autres
Publié: (2006)

Optimal designs for population pharmacokinetic studies of oral artesunate in patients with uncomplicated falciparum malaria.
par: Jamsen, K, et autres
Publié: (2011)

Pharmacokinetic predictors for recurrent malaria after dihydroartemisinin-piperaquine treatment of uncomplicated malaria in Ugandan infants.
par: Creek, D, et autres
Publié: (2013)

Dihydroartemisinin-piperaquine rescue treatment of multidrug-resistant Plasmodium falciparum malaria in pregnancy: a preliminary report.
par: Rijken, M, et autres
Publié: (2008)

Efficacy and effectiveness of dihydroartemisinin-piperaquine versus artesunate-mefloquine in falciparum malaria: an open-label randomised comparison.
par: Smithuis, F, et autres
Publié: (2006)

In vivo sensitivity monitoring of mefloquine monotherapy and artesunate-mefloquine combinations for the treatment of uncomplicated falciparum malaria in Thailand in 2003.
par: Ashley, E, et autres
Publié: (2006)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria
par: Lwin, K, et autres
Publié: (2012)

Randomized, double-blind, placebo-controlled trial of monthly versus bimonthly dihydroartemisinin-piperaquine chemoprevention in adults at high risk of malaria.
par: Lwin, K, et autres
Publié: (2012)